ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AP. Alltracel PH.

13.82
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Alltracel PH. LSE:AP. London Ordinary Share IE0030515666 ORD EUR0.0125
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 13.82 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Alltracel Pharmaceuticals Share Discussion Threads

Showing 8551 to 8573 of 8825 messages
Chat Pages: 353  352  351  350  349  348  347  346  345  344  343  342  Older
DateSubjectAuthorDiscuss
08/3/2008
14:40
First thing to establish is

''Is there a 75% acceptence required for the buyout ?''


Yes or No

Please post answer with evidence

buywell2
08/3/2008
14:31
06 - were you going to start a list of holdings? Has anybody else started one, or checked the share register to send out a circular? If you guys want to do something, best to get organised now rather than just complaining on here...
supernumerary
08/3/2008
14:30
So is there going to be a vote ? and when is the EGM ?

Viking1066 - 2 Mar'08 - 19:56 - 1983 of 2033


Well there you are then, it's a scheme of convenience :-) and not subject to takeover rules as they apply under normal Irish, UK or even EU conditions. It is the company that cancels the shares and hands back money to shareholders.

buywell2
08/3/2008
14:28
This stinks as well .... muck provided by alimo, we need an English NOMAD

Another thing, I've just discovered that the London Stock Exchange, AIM NOMAD for Alltracel is, guess who, and please consider if there is any conflict of interests having a NOMAD and adviser in the same firm of stockbrokers -

he is IVAN MURPHY,of DAVY STOCKBROKERS, Davy House,49 Dawson Street, DUBLIN

buywell2
08/3/2008
14:22
Results should show a top line of 25m compaired to las years just over 20m with Synpart kicking in circa 3.5m

These new results have great bearing on the HemCon offer and that is why the EGM MUST be after that date

buywell2
08/3/2008
14:19
Oh, and another thing, I see that people are buying at 13p. That works out at about a 7% return doesn't it? Not to be sniffed at surely?
alimo
08/3/2008
14:19
The other thing that comes to mind re the HemCon offer is .....

Alltracel were on the brink of doing a professional woundcare deal, I can name the company.

I think HemCon became aware of this information at the time of negotiations with them on the military deal.

I think if HemCon buy AP. then they will announce a major contract with a professional woundcare client within months of the buyout.

I can also reveal that AP. is in late stage negotiations with P&G re the cosmaceutical skin care product using mdoc.

I also predict that AP. will announce a CVH deal within months of the buyout. There is a company waiting to sign on the dotted line NOW.

buywell2
08/3/2008
14:14
I hope you all stay in long enough to give Hemcon a real sweat. They are relying on us all capitulating. Give me reasons why I should sell for 12.5 or 13p just now, compared to the offer of 14p later. So little difference is involved, but staying solid to reject this appalling offer gives us a vision of retaining a future interest, as the promised products materialise with all the benefits from our share of nano technology; more deals to extend our deals with Hemcon and Convatec. The hype about not getting any finance to market them (the IP) has to be bumkum. There is always finance for good products - it's the cost that matters. How much did it cost Alltracel to get the 4/5 large shareholders involved? Only what it cost the directors to do their job. We certainly shouln't have had to pay them to become involved. The fact is the share price did increase very well until decisions in June/July caused the share price to plummet. Something major happened back then to cause the retrace and we need to have questions answered. Then we borrowed from Bank of Scotland to finance the Synpart merger - the cost in August last year was obviously acceptable to both parties. The directors were very bullish about the synergies, so why the news embargo. Goodbody's are still happy with their analysis saying 22p is correct value, but with the caveat that if any one of the new products takes off, then upward of 22p can be expected.
alimo
08/3/2008
14:13
When is the EGM ?

I trust is to be AFTER the results date

buywell2
08/3/2008
14:12
There are some AP.plants here methinks
buywell2
07/3/2008
15:29
Believe me I am very disappointed and suprised. Indeed the Dutch shareholders loose a lot of money including myself. I always was possitive but now I believe it is better to sell now than hold on an other 18 months with no new good developments and the shareprice will fall down again probably. I am still in but not sure for how long
jetje
07/3/2008
14:35
Hello Jetje,

Don't hear anything from you. No comment on the things are happpening, no comfort for all the Dutch shareholders who are going to loose a fortune.
In the past you were ever in to comfort the Dutch people when the share price was
falling down - which is still miserable low - and where promising better times and recommended us to stay hopefull. I suggest you are still in for yourself with your sharecapital and suffering with us? I hope so.

marob1
07/3/2008
14:29
I also hope that the AP. results show that this deal is a giveaway

I hope AP. in its olde shape have grown by 10% plus and Synpart add 3.5m to the top line in the next set of results

buywell2
07/3/2008
14:27
Like I said

HemCon must think it is cheaper for them to buy Alltracel than pay the royalties agreed with AP. and arranged by nick hart .... such is the future market for nano based woundcare product

buywell2
07/3/2008
14:03
alimo - seems like the institutions only came in with the promise of a quick guaranteed return. that's why the reports are written as if it is a done deal.

It looks like they are no strangers to LSE enquiries

If they had robbed a bank they would be locked up.

wes1
07/3/2008
02:33
THe Bizplus article "Bloodied but Unbowed" everyone should read.



It contains an accurate description of the company up to 0606, and an even better introduction to Tony Richardson who has been at the helm since the startup prior to going public in 2001; describing his dilemma of being held up by a poor performing SP, even when profits were in sight, and revenue growth despite being spectacular between 2003 and 2006, was regarded as underwhelming by the financial gurus/gnomes. I would agree wholeheartedly with him that the share price has been very disappointing. His plans for AP. are not a corner-shop EUR25m outfit; much greater is his vision for the company, see our Authorised Capital.

I think he has done well considering he went public in the same year as 9/11 and then had to continue to steer AP. through the markets, following the Iraq War in 2003. He is the accountant that with hindsight, might wish that he had been able to delay the IPO till 2004, when turnover started to rocket. I'm sure the share price would be a lot higher, had he waited. But that's not how he and Gerard played the cards, and they needed the cash from us back in 2001 to get the SBF plasters up and running. So we small shareholders were essential to his way of thinking, back in 2001. Is that a reason for blaming us long term PI's for all AP. woes.

So, something has happened since 0606 for Tony to rethink AP. into going private again, and ditching most of his private investors into the bargain. But he's not going to lose his Alltracel, is he. But we PI's are if his scheme is allowed to succeed. He even brought 4 institutions in, but how has he managed to get their votes to help him ditch us, when with them on board he could probably look forward to a re-rating without having to sell out to Hemcon? It's a mistery, isn't it? So Tony will still be at the helm of what he must consider is his company. Except, he brought in shareholders and now should be working for ALL of them, (and not for himself and Hemcon) and especially for all those who bought in at much higher SP's, and have held for the good times that are still to come. The deal with Hemcon isn't good enough, so how does he get us all to buy it? How does he manage to get ASPartners, AXAFramlington, Appian, Investec, on his side, because he will need all their shares to succeed? How can Gerard Brandon agree that this is a good deal, when he knows how much has been spent in getting the IP to its present marketable status? Sadly, I have to presume Tony and Gerard are still buddies, and Gerard's holding can maybe be relied on. But all of them put together still isn't 75%. So how does Tony sell the scheme to the rest of us?

Do we all just doff our caps, bow our heads, shrug our shoulders with a touch to the forhead, and wave goodbye to our company. Surely a white knight can be found, that is willing to take AP. into the future. How does the deal with Convatec stand up, when Hemcon controls the nano deals. How are the Germans at Synpart reacting to this mega change, or did they know something.

wes1, I'll try putting a mic to my phone, to see if I can record what ASPartners said. If that doesn't work I'll just have to try to write down everything. I got the impression that he might have been saying that they consider that the reasons for building up a holding of 13% have changed, because AP. are no longer the attractive microcap they thought they were. How do they make this kind of change in mind, after spending a whole year thinking otherwise? Are they all going to be of the same opinion? I thought institutions are made of stronger stuff than this. Pretty feeble eh? I'm NOT saying they have all been put together to help Tony pull off the deal for Hemcon. But it would make a good story line for a novel. The title could be "Who needs the pixies, with friends like these!"

Why has a rights issue never been tried?

So how do we get organised to hold on to the 25%. How do we get the directors to release the FYE figures, with an in depth statement about the developments. Do we need to be represented at the High Court hearing, and can the scheme be fought and squashed at that stage.

alimo
06/3/2008
19:37
alimo, I cannot tell a lie - it was me
This is the article, dated June 2006, that I gave a link to.



If it doesn't work then it will be necessary to log in to here then scroll down to the pdf again and click it

wes1
06/3/2008
15:48
Yes, I agree buywell2. Wouldn't it be a shocker if it turns out to be Hemcon!! I wonder what kind of story that would make.

I'm surprised there isn't an investigating journalist interested in looking into all of what's been happening for the last 18 months. But if I remember we thought it was a company that was wanting to get their hands on the Westone part of our company.

When were Tony Richardson and Nick Hart appointed, and when did Tony Richardson make the statement about how he felt about PI's. What was said about the benefits of being a private company. Who gave the link (or is it a URL)?

alimo
06/3/2008
15:10
And why were we not told the name and more details of the last company who approached AP. ?
buywell2
06/3/2008
14:27
MLS results out on March 17th

This company still has circa 7m cash left for future aquisitions and chartwise looks to be going somewhere

Cash alone was worth 5.5p before the last purchase which was already cash generative.

If one still wants exposure to the Pharma sector I think one could do worse switching out of this stock into MLS

DYOR though

Oh and another thing , I trust MLS management ...

buywell2
06/3/2008
14:12
So presumably if less than 75% of shareholders vote in favour at the EGM all AP. shareholders will be notified/contacted to ask them to vote
buywell2
06/3/2008
14:05
Buywell just from a numbers perspective if it is 1m (assuming sterling) then the buyout is for a P/E of 21 ex debt and assuming debt of a further 5-6m on top of that, puts the P/E of 26/27. I have been critical of management for not closing deals, but I am finding it hard to make the case against it on the numbers. There would be an EGM according to the document where 75% of shareholders must vote in favour of the deal.
viking1066
06/3/2008
13:54
Will there be a vote on this buyout ?
buywell2
Chat Pages: 353  352  351  350  349  348  347  346  345  344  343  342  Older

Your Recent History

Delayed Upgrade Clock